News | January 19, 2011

Targeted Gold Nanoparticles and Radio Fields Can Treat Pancreatic Cancer

January 20, 2011 – Researchers say radiofrequency fields can successfully treat pancreatic tumors, which kill more than 95 percent of diagnosed patients. Kanzius Cancer Research Foundation (KCRF) announced research conducted in the Kanzius/Curley Lab at The University of Texas M.D. Anderson Cancer Center was published in the December 2010 issue of the American Association of Cancer Research's Clinical Cancer Research journal.

Studies found that noninvasive radiofrequency (RF) fields were effective in controlling relatively large malignant pancreatic tumors. Additionally, this process took place without any injury to surrounding tissue or changes in non-human subject behavior. The manuscript illustrates how doctors Steven A. Curley and Evan S. Glazer's studies prove that radiofrequency fields can treat pancreatic tumors
The manuscript describes the process as non-human subjects are exposed to 10 minutes of nonionizing RF radiation followed by 36 hours of treatment using targeted gold nanoparticles (AuNP). This data shows the Kanzius RF machine alongside these particular nanoparticles create an effective formula for controlling pancreatic cancer cells.

"John Kanzius, who created the RF device, once envisioned a cancer treatment that would be both effective and have zero side effects," said Curley, chief of gastrointestinal tumor surgery and program director of multidisciplinary gastrointestinal cancer care at the University of Texas M. D. Anderson Cancer Center. "These experiments demonstrate that the Kanzius RF device controls pancreatic cancer cells without any damage to nearby cells, or normal tissues and organs. We still have a lot of work to do but this is an important proof of principle."

"Every day, our team at the Kanzius Cancer Research Foundation works to help fund this incredible research," said Mark Neidig, executive director of KCRF. "These recent findings bring us one step closer to producing an effective, noninvasive cancer treatment that doesn't have the side effects associated with current treatments like chemotherapy and radiation."

This manuscript "Noninvasive Radiofrequency Field Destruction of Pancreatic Andenocarcinoma Xenografts Treated with Targeted Gold Nanoparticles" can be found at http://www.kanziuscancerresearch.org/research/published_research_manuscr....

For more information: www.Kanzius.org

Related Content

New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
Accuray TomoTherapy System Beneficial in Two Total Body Irradiation Studies
News | Radiation Therapy | June 13, 2018
Recently published data from two new studies demonstrate the benefits of Accuray’s TomoTherapy System in the delivery...
IsoRay Funding Brain Cancer Treatment Research With Ochsner Clinic Foundation
News | Brachytherapy Systems | June 12, 2018
IsoRay Inc. announced the initiation of research funding for brain cancer treatment to Ochsner Clinic Foundation, a not...
News | Brachytherapy Systems | June 07, 2018
IsoRay Inc. announced the upcoming release of its Build-Blu delivery system for real-time prostate brachytherapy.
Raysearch RayStation
Feature | Radiation Therapy | June 05, 2018 | By Melinda Taschetta-Millane
Treatment planning systems are at the heart of r...
Lung Decision Precision
News | Lung Cancer | June 04, 2018
For smokers and former smokers, the threat of lung cancer always lurks in the shadows.
Beaumont Researchers Invent New Mode of Proton Treatment for Lung Cancer
News | Proton Therapy | May 31, 2018
Members of Beaumont Health’s proton therapy team presented research on a new treatment for patients with lung cancer at...
More Than 60 Percent of Patients Seeking Proton Therapy Initially Denied Coverage
News | Proton Therapy | May 25, 2018
The Alliance for Proton Therapy Access has released a national report revealing the heavy emotional and financial...
Overlay Init